journal cover

Development and application of next generation SE36 malaria vaccine formulated with a novel adjuvant: approach to travelers' vaccine

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Jan 1, 2013

Takahiro TouganToshihiro Horii

Get paper from

Abstract

The SE36 antigen, derived from serine repeat antigen 5 (SERA5) of Plasmodium falciparum, is a promising blood stage malaria vaccine candidate. Previous clinical trials indicated the protective efficacy of BK-SE36 malaria vaccine that is constituted of SE36 recombinant protein and alumin...read more

Mentioned in this Paper

Oligodeoxyribonucleotides
Malaria Pathway
Communicable Diseases
Nonhuman primate
Ligands
Platyrrhini
Malaria Vaccines
Clinical Trial [Publication Type]
Malaria
Monkeys
Paper Details
References
  • References12
  • Citations
12
  • References12
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Plasmodium Falciparum

Malaria remains a major cause of morbidity and mortality in the tropics, with the parasite Plasmodium falciparum responsible for the majority of the disease burden. Discover the latest research on Plasmodium falciparum.

Malaria Vaccines

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

Malaria

Malaria is a mosquito-borne infectious disease that affects humans and other animals. Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches. Discover the latest research on malaria here,

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

© 2019 Meta ULC. All rights reserved

Development and application of next generation SE36 malaria vaccine formulated with a novel adjuvant: approach to travelers' vaccine

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Jan 1, 2013

Takahiro TouganToshihiro Horii

PMID: 24189556

DOI: 10.1248/yakushi.13-00212-2

Abstract

The SE36 antigen, derived from serine repeat antigen 5 (SERA5) of Plasmodium falciparum, is a promising blood stage malaria vaccine candidate. Previous clinical trials indicated the protective efficacy of BK-SE36 malaria vaccine that is constituted of SE36 recombinant protein and alumin...read more

Mentioned in this Paper

Oligodeoxyribonucleotides
Malaria Pathway
Communicable Diseases
Nonhuman primate
Ligands

Related Papers

Paper Details
References
  • References12
  • Citations
12
  • References12
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Get paper from

/papers/development-and-application-of-next-generation/24189556